128 related articles for article (PubMed ID: 38062981)
1. Esculetin unveiled: Decoding its anti-tumor potential through molecular mechanisms-A comprehensive review.
Rezoan Hossain M; Zahra Shova FT; Akter M; Shuvo S; Ahmed N; Akter A; Haque M; Salma U; Roman Mogal M; Saha HR; Sarkar BC; Sohel M
Cancer Rep (Hoboken); 2024 Jan; 7(1):e1948. PubMed ID: 38062981
[TBL] [Abstract][Full Text] [Related]
2. Esculetin suppresses proliferation of human colon cancer cells by directly targeting β-catenin.
Lee SY; Lim TG; Chen H; Jung SK; Lee HJ; Lee MH; Kim DJ; Shin A; Lee KW; Bode AM; Surh YJ; Dong Z
Cancer Prev Res (Phila); 2013 Dec; 6(12):1356-64. PubMed ID: 24104353
[TBL] [Abstract][Full Text] [Related]
3. Esculetin Inhibits Proliferation, Invasion, and Migration of Laryngeal Cancer In Vitro and In Vivo by Inhibiting Janus Kinas (JAK)-Signal Transducer and Activator of Transcription-3 (STAT3) Activation.
Zhang G; Xu Y; Zhou HF
Med Sci Monit; 2019 Oct; 25():7853-7863. PubMed ID: 31630150
[TBL] [Abstract][Full Text] [Related]
4. Esculetin exerts antitumor effect on human gastric cancer cells through IGF-1/PI3K/Akt signaling pathway.
Wang G; Lu M; Yao Y; Wang J; Li J
Eur J Pharmacol; 2017 Nov; 814():207-215. PubMed ID: 28847482
[TBL] [Abstract][Full Text] [Related]
5. In vitro anticancer effects of esculetin against human leukemia cell lines involves apoptotic cell death, autophagy, G0/G1 cell cycle arrest and modulation of Raf/MEK/ERK signalling pathway.
Wang X; Yang C; Zhang Q; Wang C; Zhou X; Zhang X; Liu S
J BUON; 2019; 24(4):1686-1691. PubMed ID: 31646826
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory Effects of Esculetin on Liver Cancer Through Triggering NCOA4 Pathway-Mediation Ferritinophagy in vivo and in vitro.
Xiu Z; Li Y; Fang J; Han J; Li S; Li Y; Yang X; Song G; Li Y; Jin N; Zhu Y; Zhu G; Sun L; Li X
J Hepatocell Carcinoma; 2023; 10():611-629. PubMed ID: 37069958
[TBL] [Abstract][Full Text] [Related]
7. Esculetin induces apoptosis of SMMC-7721 cells through IGF-1/PI3K/Akt-mediated mitochondrial pathways.
Li J; Li S; Wang X; Wang H
Can J Physiol Pharmacol; 2017 Jul; 95(7):787-794. PubMed ID: 28177662
[TBL] [Abstract][Full Text] [Related]
8. Esculetin Induces Apoptosis Through EGFR/PI3K/Akt Signaling Pathway and Nucleophosmin Relocalization.
Jeon YJ; Cho JH; Lee SY; Choi YH; Park H; Jung S; Shim JH; Chae JI
J Cell Biochem; 2016 May; 117(5):1210-21. PubMed ID: 26447856
[TBL] [Abstract][Full Text] [Related]
9. Esculetin, a natural coumarin compound, evokes Ca(2+) movement and activation of Ca(2+)-associated mitochondrial apoptotic pathways that involved cell cycle arrest in ZR-75-1 human breast cancer cells.
Chang HT; Chou CT; Lin YS; Shieh P; Kuo DH; Jan CR; Liang WZ
Tumour Biol; 2016 Apr; 37(4):4665-78. PubMed ID: 26508031
[TBL] [Abstract][Full Text] [Related]
10. Morin and Esculetin supplementation modulates c-myc induced energy metabolism and attenuates neoplastic changes in rats challenged with the procarcinogen 1,2 - dimethylhydrazine.
Sharma SH; Thulasingam S; Chellappan DR; Chinnaswamy P; Nagarajan S
Eur J Pharmacol; 2017 Feb; 796():20-31. PubMed ID: 27989504
[TBL] [Abstract][Full Text] [Related]
11. Esculetin: A review of its pharmacology and pharmacokinetics.
Zhang L; Xie Q; Li X
Phytother Res; 2022 Jan; 36(1):279-298. PubMed ID: 34808701
[TBL] [Abstract][Full Text] [Related]
12. Esculetin induces antiproliferative and apoptotic response in pancreatic cancer cells by directly binding to KEAP1.
Arora R; Sawney S; Saini V; Steffi C; Tiwari M; Saluja D
Mol Cancer; 2016 Oct; 15(1):64. PubMed ID: 27756327
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis by esculetin in human leukemia U937 cells through activation of JNK and ERK.
Park C; Jin CY; Kim GY; Choi IW; Kwon TK; Choi BT; Lee SJ; Lee WH; Choi YH
Toxicol Appl Pharmacol; 2008 Mar; 227(2):219-28. PubMed ID: 18031783
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of esculetin on arsenic trioxide-provoked apoptosis in human leukemia U937 cells.
Lin TH; Lu FJ; Yin YF; Tseng TH
Chem Biol Interact; 2009 Jun; 180(1):61-8. PubMed ID: 19428345
[TBL] [Abstract][Full Text] [Related]
15. Esculetin Protects Human Retinal Pigment Epithelial Cells from Lipopolysaccharide-induced Inflammation and Cell Death.
Ozal SA; Turkekul K; Gurlu V; Guclu H; Erdogan S
Curr Eye Res; 2018 Sep; 43(9):1169-1176. PubMed ID: 29806490
[TBL] [Abstract][Full Text] [Related]
16. Esculetin alleviates murine lupus nephritis by inhibiting complement activation and enhancing Nrf2 signaling pathway.
Zhang Y; Li Z; Wu H; Wang J; Zhang S
J Ethnopharmacol; 2022 Apr; 288():115004. PubMed ID: 35051603
[TBL] [Abstract][Full Text] [Related]
17. Esculetin Inhibits VEGF-Induced Angiogenesis Both In Vitro and In Vivo.
Park SL; Won SY; Song JH; Lee SY; Kim WJ; Moon SK
Am J Chin Med; 2016; 44(1):61-76. PubMed ID: 26916914
[TBL] [Abstract][Full Text] [Related]
18. Esculetin induces apoptosis in human gastric cancer cells through a cyclophilin D-mediated mitochondrial permeability transition pore associated with ROS.
Pan H; Wang BH; Lv W; Jiang Y; He L
Chem Biol Interact; 2015 Dec; 242():51-60. PubMed ID: 26388407
[TBL] [Abstract][Full Text] [Related]
19. Cytoprotective effects of esculetin against oxidative stress are associated with the upregulation of Nrf2-mediated NQO1 expression via the activation of the ERK pathway.
Han MH; Park C; Lee DS; Hong SH; Choi IW; Kim GY; Choi SH; Shim JH; Chae JI; Yoo YH; Choi YH
Int J Mol Med; 2017 Feb; 39(2):380-386. PubMed ID: 28000844
[TBL] [Abstract][Full Text] [Related]
20. Esculetin inhibits proliferation, migration, and invasion of clear cell renal cell carcinoma cells.
Duan J; Shi J; Ma X; Xuan Y; Li P; Wang H; Fan Y; Gong H; Wang L; Pang Y; Pang S; Yan Y
Biomed Pharmacother; 2020 May; 125():110031. PubMed ID: 32164951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
